Following our recent price drop on Wegovy we’re seeing more and more customers opting for Wegovy over Mounjaro.
Here we explain why.
Wegovy isn’t just a fallback – it’s a front-runner in its own right
It’s tempting to see Wegovy (AKA Ozempic) as a “second choice” after Mounjaro, but that’s not the case. Wegovy has been used by thousands of people in the UK and internationally, with extensive clinical trials showing average weight loss of around 15% over time.*
That kind of result is often more than enough to:
- Lower your risk of weight-related conditions
- Improve quality of life and mental wellbeing
- Support long-term, sustainable change
And with new lower prices at CheqUp, Wegovy is a smart, solid alternative – not a step down.
You’ll still be using a GLP-1 treatment with proven results
Wegovy and Mounjaro both belong to a class of medications known as GLP-1 receptor agonists. While Mounjaro also targets GIP receptors (which may enhance weight loss further), Wegovy’s single-action mechanism is:
- Simpler to dose
- Widely understood by prescribers
- Easier to manage for many users
The science behind Wegovy is robust, and the results are consistent. This isn’t a newer, less-tested option – it’s one of the most trusted treatments available.
Cost matters – and Wegovy may now offer better value
While the difference in average weight loss between the two treatments may be around 5–7%, the price difference could be much greater.
Wegovy is:
- More affordable for self-funded patients
- Offered by a wider range of providers in the UK
- Often bundled with clinical support and lifestyle coaching
If you’re thinking long-term, Wegovy (marketed as Ozempic in the USA) may provide better value and better continuity — especially as the healthcare landscape shifts.
Switching to Wegovy doesn’t mean starting over
If you’ve been using Mounjaro and are considering a switch to Wegovy, it doesn’t mean your progress has been lost. In fact, many people make the switch to Wegovy with continued long-term success.
What matters most is:
- Ongoing support from your healthcare provider
- A dose schedule that suits your needs
- A plan that includes behavioural and lifestyle support
Wegovy can be part of that – and many patients feel just as supported and confident after making the change.
Wegovy is a strong alternative to Mounjaro
Mounjaro is a promising treatment, but if cost has becomes a barrier, Wegovy stands out as a powerful, proven alternative. It’s not about choosing the “second best” – it’s about choosing what works for you, in the real world.
Check your eligibility for Wegovy now
*Wilding, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” New England Journal of Medicine, vol. 384, no. 11, 2021
